Zevra Therapeutics, Inc. (ZVRA): EPS (Basic)
$1.40
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.40 | n/m | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | -$2.28 | n/m | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | -$1.30 | n/m | 2025-03-12, From 2023-01-01 |
| 2022-12-31 | -$0.78 | n/c | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$2.11 | n/m | 2023-03-07, From 2021-01-01 |
| 2020-12-31 | -$3.21 | n/a | 2022-03-31, From 2020-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | $1.40 | n/m |
| Zymeworks Inc. (ZYME) | 2025-12-31 | -$1.08 | n/m |
| Theravance Biopharma, Inc. (TBPH) | 2025-12-31 | $2.10 | n/m |
| UroGen Pharma Ltd. (URGN) | 2025-12-31 | -$3.19 | n/m |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $0.06 | -57.1% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $0.33 | -60.2% |
| Xencor Inc (XNCR) | 2025-12-31 | -$1.24 | n/m |
| Cytokinetics Inc (CYTK) | 2025-12-31 | -$6.54 | n/m |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | -$1.27 | n/m |
Compare ZVRA, ZYME, TBPH, URGN side by side · Screen every company in Pharmaceutical Preparations ↗